By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Xanodyne Pharmaceuticals, Inc. 

7300 Turfway Road, Suite 300

Florence  Kentucky  41042  U.S.A.
Phone: 859-371-6383 Fax: 859-371-6391


SEARCH JOBS


Industry
Pharmaceutical






Company News
Mallinckrodt Inc. Announces Agreement With Xanodyne Pharmaceuticals, Inc. to Purchase RoxicodoneĀ® 8/23/2012 10:34:56 AM
Xanodyne Pharmaceuticals, Inc. Sells Drug for $26 Million to Depomed, Inc. (DEPO) 6/22/2012 8:08:55 AM
Xanodyne Pharmaceuticals, Inc. Appoints New Chief Operating Officer 5/17/2011 9:01:44 AM
Xanodyne Pharmaceuticals, Inc. to Voluntarily Withdraw Darvon(R) and Darvocet-N(R) Products 11/19/2010 9:01:26 AM
Xanodyne Pharmaceuticals, Inc. Laying Off 60 Pct of Work Force 9/24/2010 8:06:55 AM
Xanodyne Pharmaceuticals, Inc. Announces Natasha Giordano New President & CEO 5/27/2010 6:35:27 AM
Ferring Pharmaceuticals Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc. 5/10/2010 6:38:18 AM
Xanodyne Pharmaceuticals, Inc. and Ferring Pharmaceuticals, Inc. Announce Co-Promote for Zipsor(TM) 4/1/2010 10:25:23 AM
Bioniche Pharma Ltd. Adds On, Aquires Drugs from Xanodyne Pharmaceuticals, Inc. 11/16/2009 7:59:45 AM
Xanodyne Pharmaceuticals, Inc. Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules 11/13/2009 10:01:43 AM
1234
//-->